Q: Gents,
It's adequately clear (esp from some of the comments I've recently read) that the Healthcare/Pharma sector in Canada offers very few choices and even fewer good choices.
Whereas the same sector in the US offers fabulous alternatives, opportunities and growth.
I feel it is a shame to limit this weak Canadian sector in our portfolios when you can offer so much more with reccos south of the border.
Even a well represented ETF for US pharma/healthcare/bioscience might do the trick if you are time starved.
Just saying.
Sheldon
It's adequately clear (esp from some of the comments I've recently read) that the Healthcare/Pharma sector in Canada offers very few choices and even fewer good choices.
Whereas the same sector in the US offers fabulous alternatives, opportunities and growth.
I feel it is a shame to limit this weak Canadian sector in our portfolios when you can offer so much more with reccos south of the border.
Even a well represented ETF for US pharma/healthcare/bioscience might do the trick if you are time starved.
Just saying.
Sheldon